JP2015507175A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015507175A5 JP2015507175A5 JP2014544870A JP2014544870A JP2015507175A5 JP 2015507175 A5 JP2015507175 A5 JP 2015507175A5 JP 2014544870 A JP2014544870 A JP 2014544870A JP 2014544870 A JP2014544870 A JP 2014544870A JP 2015507175 A5 JP2015507175 A5 JP 2015507175A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cancer cells
- prostate specific
- prostate
- steap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161629886P | 2011-11-29 | 2011-11-29 | |
| US61/629,886 | 2011-11-29 | ||
| US201261703099P | 2012-09-19 | 2012-09-19 | |
| US61/703,099 | 2012-09-19 | ||
| PCT/US2012/066998 WO2013082249A2 (en) | 2011-11-29 | 2012-11-29 | Compositions and methods for prostate cancer analysis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015507175A JP2015507175A (ja) | 2015-03-05 |
| JP2015507175A5 true JP2015507175A5 (enExample) | 2016-01-28 |
| JP6219304B2 JP6219304B2 (ja) | 2017-10-25 |
Family
ID=47324459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014544870A Active JP6219304B2 (ja) | 2011-11-29 | 2012-11-29 | 前立腺癌分析のための組成物及び方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20130143237A1 (enExample) |
| EP (1) | EP2786151B1 (enExample) |
| JP (1) | JP6219304B2 (enExample) |
| KR (1) | KR101951514B1 (enExample) |
| CN (1) | CN104067127A (enExample) |
| AR (1) | AR089028A1 (enExample) |
| AU (1) | AU2012345926A1 (enExample) |
| BR (1) | BR112014012882A2 (enExample) |
| CA (1) | CA2854042A1 (enExample) |
| IL (1) | IL232466A (enExample) |
| MX (1) | MX350807B (enExample) |
| RU (1) | RU2641968C2 (enExample) |
| SG (1) | SG11201402711SA (enExample) |
| WO (1) | WO2013082249A2 (enExample) |
| ZA (1) | ZA201403110B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2530505B2 (ja) | 1990-03-20 | 1996-09-04 | 三ツ星ベルト株式会社 | 自着層付き防水シ―トの製造法 |
| CN105646661A (zh) * | 2014-03-24 | 2016-06-08 | 朱育盼 | 特异性结合前列腺癌的短肽pcp2及其应用 |
| JP6815331B2 (ja) * | 2015-04-21 | 2021-01-20 | ジェネンテック， インコーポレイテッド | 前立腺がんの分析のための組成物及び方法 |
| PE20200010A1 (es) | 2017-04-03 | 2020-01-06 | Hoffmann La Roche | Anticuerpos que se unen a steap-1 |
| CN108179134B (zh) * | 2017-12-27 | 2020-11-24 | 武汉大学 | 基于EpCAM/PSMA双抗体功能化微流控芯片及其制备方法和应用 |
| FI3817770T3 (fi) | 2018-07-02 | 2026-07-06 | Amgen Inc | Antigeeniä sitova anti-steap1-proteiini |
| CN114929743B (zh) * | 2019-09-05 | 2026-01-02 | 纪念斯隆凯特琳癌症中心 | 抗steap1抗体及其用途 |
| BR102020013625A2 (pt) * | 2020-07-02 | 2022-01-11 | Universidade Federal de Uberlândia | Aptâmero modificado, sistema aptaimunológico, painel aptaimunológico, kit, método e uso no diagnóstico de câncer de próstata |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US5597531A (en) | 1985-10-04 | 1997-01-28 | Immunivest Corporation | Resuspendable coated magnetic particles and stable magnetic particle suspensions |
| FI903489A7 (fi) | 1988-11-11 | 1990-07-10 | Medical Res Council | Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5698271A (en) | 1989-08-22 | 1997-12-16 | Immunivest Corporation | Methods for the manufacture of magnetically responsive particles |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| GB9114948D0 (en) | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline intermediates |
| EP0604580A1 (en) | 1991-09-19 | 1994-07-06 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| CA2372813A1 (en) | 1992-02-06 | 1993-08-19 | L.L. Houston | Biosynthetic binding protein for cancer marker |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US6046048A (en) * | 1996-01-09 | 2000-04-04 | Genetech, Inc. | Apo-2 ligand |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| WO1999041613A1 (en) | 1998-02-12 | 1999-08-19 | Immunivest | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| US6200765B1 (en) * | 1998-05-04 | 2001-03-13 | Pacific Northwest Cancer Foundation | Non-invasive methods to detect prostate cancer |
| DE69941187D1 (de) | 1998-06-01 | 2009-09-10 | Agensys Inc | Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen |
| IL129299A0 (en) * | 1999-03-31 | 2000-02-17 | Mor Research Applic Ltd | Monoclonal antibodies antigens and diagnosis of malignant diseases |
| KR100797667B1 (ko) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | 외래 유전자의 전사를 조절하는 방법 |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| BR0207290A (pt) | 2001-02-16 | 2005-06-07 | Immunivest Corp | Método para analisar um paciente quanto à presença de uma malignidade, célula maligna isolada das células cultivadas, vacina de tumor, molécula associada com diátese de tumor alterada, métodos para determinar alterações em moléculas associadas com diátese de tumor como um meio para predizer a eficácia da terapia, como um meio para analisar dosagem apropriada para terapia, como um meio para monitorar eficácia da terapia, como um meio para analisar progressão de câncer, para realizar uma biópsia de corpo inteiro em um paciente, e para identificar alterações em uma célula de tumor circulante relativamente a células presentes numa massa de tumor in situ, e, kit de teste para analisar uma amostra de paciente quanto à presença de uma célula maligna não-hematopoiética |
| US20030190602A1 (en) | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| US7219016B2 (en) | 2001-04-20 | 2007-05-15 | Yale University | Systems and methods for automated analysis of cells and tissues |
| US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| BRPI0418766B8 (pt) * | 2004-04-22 | 2021-05-25 | Agensys Inc | anticorpo ou seu fragmento, vetor, composição farmacêutica, ensaio e método para detectar a presença de proteína steap-1, bem como método para distribuir um agente citotóxico ou um agente de diagnóstico |
| US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| PT2845866T (pt) | 2006-10-27 | 2017-08-09 | Genentech Inc | Anticorpos e imunoconjugados e utilizações dos mesmos |
| CN103233063A (zh) * | 2006-11-08 | 2013-08-07 | 密歇根大学董事会 | 前列腺癌标志物spink1及其应用 |
| JP5394246B2 (ja) * | 2007-03-30 | 2014-01-22 | ジェネンテック， インコーポレイテッド | 抗体及びイムノコンジュゲートとこれらの使用方法 |
| EP2335075A4 (en) * | 2008-09-05 | 2011-12-14 | Scripps Research Inst | METHOD FOR DETECTING CIRCULATING TUMOR CELLS |
| JP5975983B2 (ja) * | 2010-04-16 | 2016-08-23 | ベリカム ファーマシューティカルズ， インコーポレイテッド | 固形腫瘍を処置するための方法 |
-
2012
- 2012-11-29 US US13/689,407 patent/US20130143237A1/en not_active Abandoned
- 2012-11-29 SG SG11201402711SA patent/SG11201402711SA/en unknown
- 2012-11-29 MX MX2014006187A patent/MX350807B/es active IP Right Grant
- 2012-11-29 JP JP2014544870A patent/JP6219304B2/ja active Active
- 2012-11-29 AU AU2012345926A patent/AU2012345926A1/en not_active Abandoned
- 2012-11-29 RU RU2014126358A patent/RU2641968C2/ru not_active IP Right Cessation
- 2012-11-29 BR BR112014012882A patent/BR112014012882A2/pt not_active Application Discontinuation
- 2012-11-29 WO PCT/US2012/066998 patent/WO2013082249A2/en not_active Ceased
- 2012-11-29 CA CA2854042A patent/CA2854042A1/en not_active Abandoned
- 2012-11-29 EP EP12798559.6A patent/EP2786151B1/en active Active
- 2012-11-29 CN CN201280067510.XA patent/CN104067127A/zh active Pending
- 2012-11-29 AR ARP120104485A patent/AR089028A1/es unknown
- 2012-11-29 KR KR1020147017563A patent/KR101951514B1/ko active Active
-
2014
- 2014-04-29 ZA ZA2014/03110A patent/ZA201403110B/en unknown
- 2014-05-05 IL IL232466A patent/IL232466A/en not_active IP Right Cessation
-
2015
- 2015-10-21 US US14/919,388 patent/US9632091B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Campos-Silva et al. | High sensitivity detection of extracellular vesicles immune-captured from urine by conventional flow cytometry | |
| Balitzer et al. | Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria | |
| Lee et al. | Aptamer-based sandwich assay and its clinical outlooks for detecting lipocalin-2 in hepatocellular carcinoma (HCC) | |
| Soh et al. | CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab | |
| JP7022191B2 (ja) | 前立腺がんの分析のための組成物及び方法 | |
| Fathi et al. | Detection of CD133-marked cancer stem cells by surface plasmon resonance: its application in leukemia patients | |
| RU2646498C2 (ru) | Способы детектирования 5Т4-положительных циркулирующих опухолевых клеток и способы диагностики 5Т4-положительного рака у млекопитающего | |
| RU2014126358A (ru) | Композиции и способы анализа рака предстательной железы | |
| HRP20160461T1 (hr) | Solubilna humana st-2 antitijela i eseji | |
| JP2017518366A5 (enExample) | ||
| JP2015533788A5 (enExample) | ||
| JP2015502547A5 (enExample) | ||
| Wang et al. | Development and application of multivalent nanobody-functionalized plasmonic probes in SERS sensing platforms | |
| Blank et al. | Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors | |
| Alston et al. | Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ? | |
| Sánchez-López et al. | Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study | |
| Forster et al. | Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells | |
| CN111886498A (zh) | 试剂盒、测定试剂盒及测定方法 | |
| Kadota et al. | Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma | |
| US20170328900A1 (en) | Methods and materials for capture antibody targeted fluorescent in-situ hybridization (cat-fish) | |
| JP2018520366A5 (enExample) | ||
| Liu et al. | Evaluation of acridine orange florescence in exfoliative urinary cytology for diagnosing bladder carcinoma | |
| JP2016504590A5 (enExample) | ||
| JP2017505911A5 (enExample) | ||
| CN121113988A (zh) | 一种用于循环肿瘤细胞检测分型的组合物及其应用 |